申请人:Acuitas Therapeutics Inc.
公开号:US20150376115A1
公开(公告)日:2015-12-31
Compounds are provided having the following structure:
or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R
1a
, R
1b
, R
2a
, R
2b
, R
3a
, R
3b
, R
4a
, R
4b
, R
5
, R
6
, R
7
, R
8
, R
9
, L
1
, L
2
, a, b, c, d and e are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.
提供具有以下结构的化合物:其中R1a,R1b,R2a,R2b,R3a,R3b,R4a,R4b,R5,R6,R7,R8,R9,L1,L2,a,b,c,d和e的药物可接受的盐,互变异构体或立体异构体,如此处所定义。还提供将该化合物用作脂质纳米粒子配方的组分,用于传递治疗剂的组成物以及其使用和制备方法。